Zimmer Biomet Announces Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Zimmer Biomet (ZBH) PT Lowered to $175 at Jefferies
November 5, 2021 8:17 AM EDTJefferies analyst Raj Denhoy lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $200.00) while maintaining a Buy rating.
The analyst commented, "Key 2Q post call details: 1) Delta/Staffing impacts are expected to persist into 4Q at heightened level, 2) China VBP... More
Zimmer Biomet (ZBH) PT Lowered to $175 at Truist Securities
November 4, 2021 6:09 PM EDTTruist Securities analyst Kaila Krum lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $188.00) while maintaining a Buy rating.
The analyst commented, "The third quarter was another noisy event for Zimmer Biomet headlined by COVID, staffing, and VBP headwinds that impacted... More
Zimmer Biomet (ZBH) PT Lowered to $175 at Needham & Company
November 4, 2021 1:45 PM EDTNeedham & Company analyst Mike Matson lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $187.00) while maintaining a Strong Buy rating.
The analyst commented, "ZBH's 3Q21 revenue missed while EPS beat consensus. Growth slowed due to procedure disruption and a tougher comp... More
Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 1c, Lowers FY Guidance
November 4, 2021 6:34 AM EDTZimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.81, $0.01 better than the analyst estimate of $1.80. Revenue for the quarter came in at $1.92 billion versus the consensus estimate of $1.96 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2021 EPS of $7.32-$7.47, versus the consensus of... More
